Emergent BioSolutions EBS
NYSE EBS
$4.91 +0.02 (+0.31%)
As of: Aug 20, 2026 · 3:49 PM EDT

Emergent BioSolutions (EBS) Shares Outstanding (Entity) (2010 - 2026)

Emergent BioSolutions (EBS) Shares Outstanding (Entity) (2010 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Haleon 43.83 Bn 42.86 Bn - 4.44 Bn
2 Teva Pharmaceutical Industries 42.85 Bn 39.19 Bn 2.15 Bn 1.17 Bn
3 Zoetis 31.40 Bn 29.73 Bn 1.05 Bn 414.15 Mn
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn -
5 United Therapeutics 22.16 Bn 19.49 Bn 683.80 Mn 42.68 Mn
6 Viatris 18.71 Bn 17.83 Bn 1.46 Bn 1.15 Bn
7 Neurocrine Biosciences 15.42 Bn 15.03 Bn 935.80 Mn 101.60 Mn
8 Elanco Animal Health 11.70 Bn 11.17 Bn 798.00 Mn 499.55 Mn
9 Dr Reddys Laboratories 10.09 Bn 9.93 Bn - 834.66 Mn
10 Emergent BioSolutions 253.61 Mn 112.71 Mn 137.20 Mn 51.30 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 61.90 Mn
Mar 31, 2026 61.40 Mn
Dec 31, 2025 60.90 Mn
Sep 30, 2025 60.60 Mn
Jun 30, 2025 60.40 Mn
Mar 31, 2025 60.10 Mn
Dec 31, 2024 59.90 Mn
Sep 30, 2024 59.70 Mn
Jun 30, 2024 58.50 Mn
Mar 31, 2024 58.00 Mn
Dec 31, 2023 57.80 Mn
Sep 30, 2023 57.40 Mn
Jun 30, 2023 57.40 Mn
Mar 31, 2023 56.00 Mn
Dec 31, 2022 55.70 Mn
Sep 30, 2022 55.50 Mn
Jun 30, 2022 55.50 Mn
Mar 31, 2022 55.30 Mn
Dec 31, 2021 55.10 Mn
Sep 30, 2021 54.90 Mn